A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy

Clinical trial NCT06647134 · RECRUITING

Trial details

NCT number: NCT06647134
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Arthritis Polymyalgia Rheumatica Immune Checkpoint Inhibitors

Start date: 2024-09-11
Primary completion: 2028-03-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.